High Dose Chemotherapy and Autologous Transplant for Breast Cancer
Phase 2
- Conditions
- Graft vs Host Disease
- Registration Number
- NCT00186641
- Lead Sponsor
- Stanford University
- Brief Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Stage II, III or IV breast cancer
- chemosensitive
- adequate organ function
Exclusion Criteria
- prior transplant,
- life threatening disease
- brain metastases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Survival
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University Cancer Center
🇺🇸Stanford, California, United States